These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8300059)

  • 1. Growth response to growth hormone during the first year as a diagnosis criterion of growth hormone deficiency.
    Zantleifer D; Awadalla S; Brauner R
    Horm Res; 1993; 40(4):123-7. PubMed ID: 8300059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capacity to increase GH secretion at puberty reflects the severity of GH deficiency.
    Pauwels C; Souberbielle JC; Prévot-Saucet C; Brauner R
    Horm Res; 1992; 38(3-4):140-4. PubMed ID: 1306845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic markers of permanent idiopathic growth hormone deficiency.
    Adan L; Souberbielle JC; Brauner R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):353-8. PubMed ID: 7508948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of the L-Dopa and clonidine GH stimulation tests in patients with endogenous growth hormone deficiency - retrospective analysis after discontinuation of treatment - own experience].
    Petriczko E; Szmit-Domagalska J; Horodnicka-Józwa A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):13-9. PubMed ID: 19454184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone state after completion of treatment with growth hormone.
    Clayton PE; Price DA; Shalet SM
    Arch Dis Child; 1987 Mar; 62(3):222-6. PubMed ID: 3566314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings.
    Coutant R; Rouleau S; Despert F; Magontier N; Loisel D; Limal JM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the growth hormone response to growth hormone-releasing hormone in children with idiopathic growth hormone deficiency.
    Groisne C; Trivin C; Souberbielle JC; Brauner R
    Horm Res; 2002; 58(2):94-8. PubMed ID: 12207169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in the diagnosis of growth hormone deficiency.
    Argyropoulou M; Perignon F; Brauner R; Brunelle F
    J Pediatr; 1992 Jun; 120(6):886-91. PubMed ID: 1593348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient.
    Cacciari E; Tassoni P; Cicognani A; Pirazzoli P; Salardi S; Balsamo A; Cassio A; Zucchini S; Colli C; Tassinari D
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1663-9. PubMed ID: 7989472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic growth hormone deficiency: presentation, diagnostic and treatment during childhood.
    Pinto G; Adan L; Souberbielle JC; Thalassinos C; Brunelle F; Brauner R
    Ann Endocrinol (Paris); 1999 Sep; 60(3):224-31. PubMed ID: 10520414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.